Literature DB >> 21685691

MAGI1 inhibits cancer cell migration and invasion of hepatocellular carcinoma via regulating PTEN.

Gewen Zhang1, Zhiming Wang.   

Abstract

OBJECTIVE: To explore the biological function and molecular mechanism of membrane associated guanylate kinase, WW and PDZ domain containing 1 (MAGI1) in hepatocellular carcinoma.
METHODS: HepG2(MAGI1) stable cell line was constructed by transfecting HepG2 cells with pcDNA3.1-MAGI1 plasmid. Wound healing and invasion assay were performed to compare the migration and invasion ability of HepG2(MAGI1) and HepG2 cells. Furthermore, the expression of MAGI1 and phosphatase and tensin homolog deleted on chromosome ten (PTEN) was also examined by Western blot and the relationship was analyzed.
RESULTS: The wound healing assay showed that the closure of HepG2(MAGI1) cells was significantly slower than that of HepG2 cells [(90 ± 10)% vs. (50 ± 15)%, P<0.05], and the invasion assay showed that the number of HepG2(MAGI1) cells that passed through the matrigel was fewer than HepG2 cells (68 ± 18 vs. 150 ± 30, P<0.05). The protein expression level of PTEN was significantly elevated in HepG2(MAGI1) cells compared with HepG2 cells (1.40 ± 0.32 vs. 0.28 ± 0.15, P<0.05). MAGI1 and PTEN protein expression levels were positively correlated (r=0.913, P<0.01).
CONCLUSION: MAGI1 may inhibit the cancer cell migration and invasion of hepatocellular carcinoma via regulating PTEN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685691     DOI: 10.3969/j.issn.1672-7347.2011.05.002

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  7 in total

1.  MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.

Authors:  Takashi Kozakai; Masahiko Takahashi; Masaya Higuchi; Toshifumi Hara; Kousuke Saito; Yuetsu Tanaka; Masayoshi Masuko; Jun Takizawa; Hirohito Sone; Masahiro Fujii
Journal:  Int J Hematol       Date:  2017-10-17       Impact factor: 2.490

2.  MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer.

Authors:  Shuqin Jia; Jiajia Lu; Tingting Qu; Yi Feng; Xiaohong Wang; Caixia Liu; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

3.  The Evaluation of WBP2NL-Related Genes Expression in Breast Cancer.

Authors:  Seyedmehdi Nourashrafeddin; Mahmoud Aarabi; Mohammad Hosein Modarressi; Marveh Rahmati; Mohammad Nouri
Journal:  Pathol Oncol Res       Date:  2014-11-25       Impact factor: 3.201

4.  Silencing Of MAGI1 Promotes The Proliferation And Inhibits Apoptosis Of Glioma Cells Via The Wnt/β-Catenin And PTEN/AKT Signaling Pathways.

Authors:  Yongzhi Lu; Wei Sun; Liang Zhang; Junyao Li
Journal:  Onco Targets Ther       Date:  2019-11-13       Impact factor: 4.147

5.  MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis.

Authors:  Emilie Bousquet Mur; Maicol Mancini; Diala Kantar; Vera Slaninova; Yezza Ben Salah; Luca Costa; Elodie Forest; Patrice Lassus; Charles Géminard; Florence Boissière-Michot; Béatrice Orsetti; Charles Theillet; Jacques Colinge; Christine Benistant; Antonio Maraver; Lisa Heron-Milhavet; Alexandre Djiane
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

6.  Age-associated genes in human mammary gland drive human breast cancer progression.

Authors:  Xiang Gu; Bingzhi Wang; Haiyan Zhu; You Zhou; Aaron M Horning; Tim H-M Huang; Yidong Chen; Peter Houghton; Zhao Lai; Joel E Michalek; Lu-Zhe Sun
Journal:  Breast Cancer Res       Date:  2020-06-15       Impact factor: 6.466

7.  MAGI1 Inhibits the Proliferation, Migration and Invasion of Glioma Cells.

Authors:  Zhong-Yan Li; Xue-Hua Li; Guang-Wei Tian; Dong-Yong Zhang; Hai Gao; Zhen-Yu Wang
Journal:  Onco Targets Ther       Date:  2019-12-19       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.